DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Precancerous Conditions D011230 48 associated lipids
Carcinoma D002277 18 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Dementia D003704 2 associated lipids
Heart Failure D006333 36 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Brain Neoplasms D001932 15 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Koletzko B et al. Does dietary DHA improve neural function in children? Observations in phenylketonuria. 2009 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:19615874
Brenna T Tissue-specific LCPUFA accretion in fetal humans. 2012 Jan-Feb Prostaglandins Leukot. Essent. Fatty Acids pmid:22078006
Harris MA et al. Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11487304
Kenchegowda S et al. Involvement of pigment epithelium-derived factor, docosahexaenoic acid and neuroprotectin D1 in corneal inflammation and nerve integrity after refractive surgery. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:22579364
Westphal C et al. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease? 2011 Prostaglandins Other Lipid Mediat. pmid:21945326
Weylandt KH et al. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. 2012 Prostaglandins Other Lipid Mediat. pmid:22326554
Giudetti AM and Cagnazzo R Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases. 2012 Prostaglandins Other Lipid Mediat. pmid:23064030
Kim HY et al. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. 2011 Prostaglandins Other Lipid Mediat. pmid:21810478
Recchiuti A Resolvin D1 and its GPCRs in resolution circuits of inflammation. 2013 Prostaglandins Other Lipid Mediat. pmid:23500003
Gladyshev MI et al. Production of EPA and DHA in aquatic ecosystems and their transfer to the land. 2013 Prostaglandins Other Lipid Mediat. pmid:23500063
Serhan CN et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. 2004 Prostaglandins Other Lipid Mediat. pmid:15290791
Wagner K et al. Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. 2011 Prostaglandins Other Lipid Mediat. pmid:21854866
von Schacky C The Omega-3 Index as a risk factor for cardiovascular diseases. 2011 Prostaglandins Other Lipid Mediat. pmid:21726658
Monia ZA et al. Docosahexaenoic acid reduces both cyclic nucleotide and melatonin synthesis in rat pinealocytes. 1998 Prostaglandins Other Lipid Mediat. pmid:9653768
Rapoport SI et al. Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. 2011 Prostaglandins Other Lipid Mediat. pmid:21704722
Taber DF and Jackson Roberts L Nomenclature systems for the neuroprostanes and for the neurofurans. 2005 Prostaglandins Other Lipid Mediat. pmid:16303600
Hong S et al. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis. 2005 Prostaglandins Other Lipid Mediat. pmid:16303609
Yuan J et al. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. 2010 Prostaglandins Other Lipid Mediat. pmid:20394833
Seki H et al. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. 2009 Prostaglandins Other Lipid Mediat. pmid:19737659
Hishinuma T et al. Effects of long-term supplementation of eicosapentanoic and docosahexanoic acid on the 2-, 3-series prostacyclin production by endothelial cells. 1999 Prostaglandins Other Lipid Mediat. pmid:10480487
Shi H et al. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. 2016 Prostaglandins Other Lipid Mediat. pmid:27026343
Niemoller TD and Bazan NG Docosahexaenoic acid neurolipidomics. 2010 Prostaglandins Other Lipid Mediat. pmid:19804838
Shaikh IA et al. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. 2008 Prostate pmid:18668525
Cavazos DA et al. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. 2011 Prostate pmid:21360560
Nadalin S et al. Niacin skin flush test: a research tool for studying schizophrenia. 2010 Psychiatr Danub pmid:20305586
Buretić-Tomljanović A et al. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia. 2008 Psychiatr Danub pmid:18827766
Mischoulon D and Freeman MP Omega-3 fatty acids in psychiatry. 2013 Psychiatr. Clin. North Am. pmid:23538073
Rees AM et al. Omega-3 deficiency associated with perinatal depression: case control study. 2009 Psychiatry Res pmid:19268372
Parker GB et al. Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. 2006 Psychiatry Res pmid:16499974
Lucas M et al. Plasma omega-3 and psychological distress among Nunavik Inuit (Canada). 2009 Psychiatry Res pmid:19394089
Kale A et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. 2010 Psychiatry Res pmid:19969375
Buydens-Branchey L and Branchey M Long-chain n-3 polyunsaturated fatty acids decrease feelings of anger in substance abusers. 2008 Psychiatry Res pmid:17900705
McNamara RK et al. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. 2008 Psychiatry Res pmid:18715653
Conklin SM et al. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. 2007 Psychiatry Res pmid:17383013
Mocking RJ et al. Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression. 2013 Psychoneuroendocrinology pmid:23465556
Levant B et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats. 2008 Psychoneuroendocrinology pmid:18707812
Mitsuhashi N and Kato J Modulation of steroid hormone receptors in the brain--inhibitory effect of fatty acids on the binding between cytosol progestin receptors in the rat cortex and R5020. 1987 Psychoneuroendocrinology pmid:2955444
McNamara RK et al. Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: role of ovarian hormones and dietary omega-3 fatty acid composition. 2009 Psychoneuroendocrinology pmid:19046819
Kim HW et al. Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain. 2012 Psychopharmacology (Berl.) pmid:22414961
Bazinet RP et al. Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder. 2006 Psychopharmacology (Berl.) pmid:16344985
Lee LK et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. 2013 Psychopharmacology (Berl.) pmid:22932777
Bazinet RP et al. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat. 2005 Psychopharmacology (Berl.) pmid:15986187
Conklin SM et al. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. 2007 Psychosom Med pmid:17991818
Amin AA et al. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. 2008 Psychosom Med pmid:18842751
Lucas M et al. Plasma n-3 fatty acids and psychological distress in aboriginal Cree Indians (Canada). 2009 Public Health Nutr pmid:19243672
Abu-Saad K et al. Rapid assessment tools for ranking pregnant minority women into multi-nutrient exposure groups. 2011 Public Health Nutr pmid:20519048
Maqbool A et al. The skinny on tuna fat: health implications. 2011 Public Health Nutr pmid:21324226
Lucas M et al. n-3 Fatty acid intake from marine food products among Quebecers: comparison to worldwide recommendations. 2010 Public Health Nutr pmid:19433004
Mendez MA et al. Maternal fish and other seafood intakes during pregnancy and child neurodevelopment at age 4 years. 2009 Public Health Nutr pmid:19026093
Lucas M et al. Validation of an FFQ for evaluation of EPA and DHA intake. 2009 Public Health Nutr pmid:19102810